NCT01773733已完成不适用
All-Russia Non-interventional Program of Reduxine Safety Monitoring for Weight Reduction in Patients With Alimentary Obesity in the Routine Clinical Practice
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 98,774
- 主要终点
- Body Weight Loss After 3, 6 & 12 Month Treatment
研究概览
简要总结
The aim of this study is to summarize the data on efficacy and safety of Reduxine administration in the routine clinical practice according to the approved indications.
详细描述
Secondary objectives:
- to study the structure of the population of patients with the diet induced obesity with body mass index (BMI) 30 kg/m2 or diet induced obesity with BMI ≥27 kg/m2 associated with type 2 diabetes mellitus in respect of comorbidities and concomitant treatment to determine the areas for further investigations.
- to introduce the elements of control of adverse cardiovascular risks into the routine clinical practice: questionnaire concerning enrollment criteria for Reduxine treatment initiation, algorithm of Reduxine administration and treatment efficacy and safety monitoring (assessment schedule).
- to assess the effects of the treatment of overweight and obesity with Reduxine on patients' quality of life parameters.
The Time Frame: the follow up of the study patients will be performed during six month to one year. Exception - premature discontinuation from the study.
The scheduled visits of the patients to the investigational centres are: Week0 (inclusion of the patient), Week 2, 4, 6, 8, 10, 12, 16, 20, 24, 36 and Week 48.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women of 18-65 years of age to whom, in the doctor's opinion, the on-label use of Reduxine is indicated.
- •Patient's desire and ability to participate in the program and fulfill the doctor's instructions designed to achieve the treatment goal and the program requirements compliance.
- •Signed informed consent form for participation in the program.
排除标准
- •Patients under age of 18 or older than 65;
- •Current or the history of:
- •coronary artery disease (e.g. angina, myocardial infraction);
- •congestive heart failure;
- •tachycardia;
- •peripheral arterial occlusive disease;
- •arrythmia;
- •Uncontrolled arterial hypertension >145/90 mm Hg;
- •Hypersensitivity to sibutramine or any components of Reduxine®;
- •Current use of monoamineoxidase inhibitors (IMAO) or their use within the last 2 weeks;
- •Current use of other central acting weight reducing drugs or their use within the last 2 weeks;
- •Use on other drugs affecting the central nervous system (e.g. antidepressants, neuroleptics); tryptophan-containing drugs indicated for sleep disturbance;
- •Severe eating disorder (anorexia nervosa or bulimia);
- •Mental disease;
- •Gilles de la Tourette syndrome (generalized tics);
- •Body mass index ≤30 kg/m2 or ≤27 kg/m2 in the presence of concomitant diseases (dyslipidemia, diabetes);
- •Organic cause of obesity (e.g. hypothyrosis);
- •Thyrotoxicosis;
- •Sever liver and/or kidney function abnormality;
- •Benign prostatic hyperplasia;
- •Phaeochromocytoma;
- •Narrowangle glaucoma;
- •Documented pharmacologic, drug or alcohol addiction;
- •Pregnancy and lactation;
- •Refusal to sign the informed consent form for participation in the program;
- •Participation in a clinical study of any new drug product within 90 days prior to the screening visit.
结局指标
主要结局
Body Weight Loss After 3, 6 & 12 Month Treatment
时间窗: Baseline, after 3, 6 and 12 months of treatment.
Patients were weighed at each visit, but the statistical data processing was carried out after 3, 6 and 12 months of treatment.
次要结局
- Percentage of Participants With Adverse Events(From the 1st day of Reduxine treatment until the end of the treatment)
研究者
相似试验
尚未招募
1 期
To study the effect of Tila tail matra basti in dysmenorrhoeaCTRI/2020/04/024850Dr Neelam Lallan prasad Yadav
招募中
3 期
Exploratory clinical study of silkworm cordyceps for targeting dementia patientsDementiaJPRN-jRCTs031200291Hiroyuki Osawa40
尚未招募
不适用
Effect Of Tila Shelu Karvi Kwath With Hingu triguna Taila Matra Basti On Scanty MensesCTRI/2022/11/047242Madan Mohan Malviya Govt. Ayurved College Udaipur
尚未招募
Unknown
ebulization with 3% hypertonic saline vs adrenaline in Acute bronchiolitisCTRI/2023/05/052255Dr. Anupama Singh
已完成
不适用
A Clinical Trial to study the Safety and Efficacy of Litemeds pain Management Device in Subjects with musculoskeletal PaiCTRI/2022/07/043775itemed India Private Limited240